Funder: Alpha-1 Foundation
Due Dates: September 25, 2026 (LOI) | November 27, 2026 (Invitation notification) | February 12, 2027 (Full application) | April 2027 (Funding decisions)
Funding Amounts: Up to $75,000 per year for up to two years; maximum total award of $150,000
Summary: Supports mentored postdoctoral research on alpha-1 antitrypsin deficiency to improve treatment, care, and progress toward a cure.
Key Information: Full applications are by invitation following LOI review; pharmaceutical, biotech, and industry entities cannot apply or collaborate.
Description
The Alpha-1 Foundation’s Postdoctoral Research Fellowship supports fellows starting their research careers in established laboratories or under the mentorship of established researchers. Part of the 2026–2027 In-Cycle Grants Award Program, it is intended for fellows pursuing careers in alpha-1 antitrypsin deficiency (AATD) research. The program combines research support with scientific training and mentor interaction.
Supported work includes basic science, clinical research, and ethical, legal, and social issues related to AAT deficiency. The Foundation’s broader priorities include understanding disease mechanisms, developing and testing treatments, and improving care for Alpha-1-related lung and liver disease. Its ultimate goals are to improve the health and lives of people affected by AAT deficiency and find a cure.
